These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 19477353)

  • 1. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease.
    Tang TY; Howarth SP; Miller SR; Graves MJ; Patterson AJ; U-King-Im JM; Li ZY; Walsh SR; Brown AP; Kirkpatrick PJ; Warburton EA; Hayes PD; Varty K; Boyle JR; Gaunt ME; Zalewski A; Gillard JH
    J Am Coll Cardiol; 2009 Jun; 53(22):2039-50. PubMed ID: 19477353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo carotid plaque MRI using quantitative T2* measurements with ultrasmall superparamagnetic iron oxide particles: a dose-response study to statin therapy.
    Patterson AJ; Tang TY; Graves MJ; Müller KH; Gillard JH
    NMR Biomed; 2011 Jan; 24(1):89-95. PubMed ID: 21259368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI.
    Tang T; Howarth SP; Miller SR; Trivedi R; Graves MJ; King-Im JU; Li ZY; Brown AP; Kirkpatrick PJ; Gaunt ME; Gillard JH
    Stroke; 2006 Sep; 37(9):2266-70. PubMed ID: 16917091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI.
    Trivedi RA; U-King-Im JM; Graves MJ; Cross JJ; Horsley J; Goddard MJ; Skepper JN; Quartey G; Warburton E; Joubert I; Wang L; Kirkpatrick PJ; Brown J; Gillard JH
    Stroke; 2004 Jul; 35(7):1631-5. PubMed ID: 15166394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages.
    Trivedi RA; Mallawarachi C; U-King-Im JM; Graves MJ; Horsley J; Goddard MJ; Brown A; Wang L; Kirkpatrick PJ; Brown J; Gillard JH
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1601-6. PubMed ID: 16627809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin and uptake of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) in human monocyte-macrophages: implications for magnetic resonance imaging.
    Müller K; Skepper JN; Tang TY; Graves MJ; Patterson AJ; Corot C; Lancelot E; Thompson PW; Brown AP; Gillard JH
    Biomaterials; 2008 Jun; 29(17):2656-62. PubMed ID: 18377983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in arterial wall strain with aggressive lipid-lowering therapy in patients with carotid artery disease.
    Li ZY; Tang TY; Jiang F; Zhang Y; Gillard JH
    Circ J; 2011; 75(6):1486-92. PubMed ID: 21483158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron oxide magnetic resonance imaging for atherosclerosis therapeutic evaluation: still "rusty?".
    Fayad ZA; Razzouk L; Briley-Saebo KC; Mani V
    J Am Coll Cardiol; 2009 Jun; 53(22):2051-2. PubMed ID: 19477354
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques in patients with asymptomatic carotid stenosis undergoing coronary artery bypass grafting: an ultrasmall superparamagnetic iron oxide enhanced magnetic resonance study.
    Tang TY; Howarth SP; Miller SR; Graves MJ; U-King-Im JM; Li ZY; Walsh SR; Hayes PD; Varty K; Gillard JH
    Eur J Vasc Endovasc Surg; 2008 Apr; 35(4):392-8. PubMed ID: 18171628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of carotid atheromatous plaque inflammation with biomechanical stress: utility of USPIO enhanced MR imaging and finite element analysis.
    Tang TY; Howarth SP; Li ZY; Miller SR; Graves MJ; U-King-Im JM; Trivedi RA; Walsh SR; Brown AP; Kirkpatrick PJ; Gaunt ME; Gillard JH
    Atherosclerosis; 2008 Feb; 196(2):879-87. PubMed ID: 17350023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging.
    Corot C; Petry KG; Trivedi R; Saleh A; Jonkmanns C; Le Bas JF; Blezer E; Rausch M; Brochet B; Foster-Gareau P; Balériaux D; Gaillard S; Dousset V
    Invest Radiol; 2004 Oct; 39(10):619-25. PubMed ID: 15377941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation.
    Smits LP; Tiessens F; Zheng KH; Stroes ES; Nederveen AJ; Coolen BF
    Atherosclerosis; 2017 Aug; 263():211-218. PubMed ID: 28662398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.
    Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Liapis CD
    J Vasc Surg; 2010 Jan; 51(1):114-21. PubMed ID: 19837545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability.
    Metz S; Beer AJ; Settles M; Pelisek J; Botnar RM; Rummeny EJ; Heider P
    Int J Cardiovasc Imaging; 2011 Jul; 27(6):901-12. PubMed ID: 20972832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E
    Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of ultrasmall superparamagnetic iron oxide-enhanced MRI of carotid atherosclerosis to assess risk of cerebrovascular and cardiovascular events: follow-up of the ATHEROMA trial.
    Degnan AJ; Patterson AJ; Tang TY; Howarth SP; Gillard JH
    Cerebrovasc Dis; 2012; 34(2):169-73. PubMed ID: 22922841
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of atorvastatin on carotid atherosclerotic plaques: a randomized trial for quantitative tissue characterization of carotid atherosclerotic plaques with integrated backscatter ultrasound.
    Yamada K; Yoshimura S; Kawasaki M; Enomoto Y; Asano T; Minatoguchi S; Iwama T
    Cerebrovasc Dis; 2009; 28(4):417-24. PubMed ID: 19707015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques contralateral to symptomatic carotid stenosis: an ultra small superparamagnetic iron oxide enhanced magnetic resonance study.
    Tang TY; Howarth SP; Miller SR; Graves MJ; U-King-Im JM; Trivedi RA; Li ZY; Walsh SR; Brown AP; Kirkpatrick PJ; Gaunt ME; Gillard JH
    J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1337-43. PubMed ID: 17578854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin.
    Qi C; Deng L; Li D; Wu W; Gong L; Li Y; Zhang Q; Zhang T; Zhang C; Zhang Y
    PLoS One; 2015; 10(5):e0125677. PubMed ID: 25973795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential imaging of asymptomatic carotid atheroma using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging: a feasibility study.
    Sadat U; Howarth SP; Usman A; Tang TY; Graves MJ; Gillard JH
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e271-6. PubMed ID: 22841932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.